Northern Trust
IMMX icon

Northern Trust’s Immix Biopharma IMMX Stock Holding History

Northern Trust’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31M Buy
418,051
+279,819
+202% +$2.6M ﹤0.01% 2699
2026
Q1 		$1.26M Buy
138,232
+37,574
+37% +$276K ﹤0.01% 3219
2025
Q4 		$526K Buy
100,658
+11,357
+13% +$46.7K ﹤0.01% 3638
2025
Q3 		$187K Sell
89,301
-4,587
-5% -$11K ﹤0.01% 4003
2025
Q2 		$194K Sell
93,888
-1,374
-1% -$2.77K ﹤0.01% 3944
2025
Q1 		$160K Buy
95,262
+56,348
+145% +$106K ﹤0.01% 4001
2024
Q4 		$85.6K Hold
38,914
– – ﹤0.01% 4183
2024
Q3 		$58K Hold
38,914
– – ﹤0.01% 4174
2024
Q2 		$77K Hold
38,914
– – ﹤0.01% 4107
2024
Q1 		$119K Buy
38,914
+14,536
+60% +$56.3K ﹤0.01% 4029
2023
Q4 		$169K Buy
+24,378
New +$110K ﹤0.01% 3951
2023
Q1 		– Sell
-19,151
Closed -$43.9K – 4603
2022
Q4 		$43.9K Hold
19,151
– – ﹤0.01% 4308
2022
Q3 		$26K Buy
+19,151
New +$41.9K ﹤0.01% 4498

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's IMMX Position: Q2 2026 in Review

Northern Trust increased its Immix Biopharma (IMMX) stake by 202% in Q2 2026, buying an estimated $2.6M and bringing the position to 418,051 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2699.

Northern Trust first reported a position in IMMX in Q3 2022 and has held it in 13 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Northern Trust held 418,051 shares of Immix Biopharma worth $4.31M as of Q2 2026.
  • Northern Trust bought 279,819 Immix Biopharma shares in Q2 2026, an estimated $2.6M.
  • Immix Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2699 holding.
  • Northern Trust first reported a position in Immix Biopharma in Q3 2022 and has held it in 13 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.